Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hye-Youn | - |
dc.contributor.author | Lee, Kyung-Min | - |
dc.contributor.author | Kim, So-Hyun | - |
dc.contributor.author | Kwon, Yeo-Jung | - |
dc.contributor.author | Chun, Young-Jin | - |
dc.contributor.author | Choi, Hyung-Kyoon | - |
dc.date.available | 2019-01-22T14:22:44Z | - |
dc.date.issued | 2016-10-11 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/1682 | - |
dc.description.abstract | This study conducted comprehensive and comparative metabolic and lipidomic profiling of a human epithelial breast cell line (MCF-10A), a slightly metastatic (MCF-7), and a highly metastatic (MDA-MB-231) breast cancer cell line using gas chromatography mass spectrometry (GC-MS) and direct infusion mass spectrometry (DI-MS). Among 39 metabolites identified by GC-MS analysis, xanthine, glucose-6-phosphate, mannose-6-phosphate, guanine, and adenine were selected as prognostic markers of breast cancer metastasis. Major metabolic pathways involved in differentiation of the cell lines were alanine, aspartate, and glutamate metabolism, purine metabolism and glycine, serine, and threonine metabolism. Among 44 intact lipid species identified by DI-MS analysis, the levels of most phospholipids were higher in both metastatic groups than in normal cells. Specifically, the levels of phosphatidylserine (PS) 18: 0/20: 4, phosphatidylinositol (PI) 18: 0/20: 4, and phosphatidylcholine (PC) 18: 0/20: 4 were markedly higher while those of phosphatidylethanolamine (PE) 18: 1/18: 1 and PI 18: 0/18: 1 were lower in MDA-MB-231 cells than in MCF-7 cells. A partial-least-squares regression model was developed and validated for predicting the metastatic potential of breast cancer cells. The information obtained in this study will be useful when developing diagnostic tools and for identifying potential therapeutic targets for metastatic breast cancer. | - |
dc.format.extent | 18 | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.title | Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials | - |
dc.type | Article | - |
dc.identifier.doi | 10.18632/oncotarget.11560 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.7, no.41, pp 67111 - 67128 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000387446200060 | - |
dc.identifier.scopusid | 2-s2.0-84994048515 | - |
dc.citation.endPage | 67128 | - |
dc.citation.number | 41 | - |
dc.citation.startPage | 67111 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 7 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | metastasis | - |
dc.subject.keywordAuthor | breast cancer cells | - |
dc.subject.keywordAuthor | metabolomics | - |
dc.subject.keywordAuthor | lipidomics | - |
dc.subject.keywordAuthor | PLSR | - |
dc.subject.keywordPlus | TUMOR-CELLS | - |
dc.subject.keywordPlus | SPECTROMETRY | - |
dc.subject.keywordPlus | GENES | - |
dc.subject.keywordPlus | CARCINOMAS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | REVEALS | - |
dc.subject.keywordPlus | BLOOD | - |
dc.subject.keywordPlus | LINES | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordPlus | SUBTYPES | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.